Vaccine News and Research

Latest Vaccine News and Research

Pennsylvanians at-risk for H1N1 flu receive H1N1 vaccination

Governor Edward G. Rendell today announced that 100,000 Pennsylvanians at-risk for the H1N1 flu were vaccinated during the weekend at public health clinics held by the Department of Health and local health departments.

25 Nov 2009

Health watch: When you eat just as vital to what you eat

When you eat may be just as vital to your health as what you eat, found researchers at the Salk Institute for Biological Studies. Their experiments in mice revealed that the daily waxing and waning of thousands of genes in the liver—the body's metabolic clearinghouse—is mostly controlled by food intake and not by the body's circadian clock as conventional wisdom had it.

25 Nov 2009

Emerging cancer vaccines: Forecasts, new developments and pipeline analysis

The H1N1 vaccine has spurred media interest in vaccines, as well as predictions of vaccines for a host of new diseases. According to Kalorama Information, certain cancers may be added to the list of diseases for which vaccinations will be employed.

25 Nov 2009

Pharmaceutical research and biotechnology companies test medicines and vaccines to treat HIV/AIDS

America's pharmaceutical research and biotechnology companies are testing 97 medicines and vaccines to treat or prevent HIV/AIDS and related conditions, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).

25 Nov 2009

Several new vaccines require booster shots to remain effective during a lifetime: Study

Preventing disease is the goal of every health care provider and fortunately every year, new vaccines are being added to assist in disease prevention. But do all vaccines boost immunity for the same period of time? And, if not, when are additional 'booster shots' needed to keep immunity strong?

24 Nov 2009

Africa region leaders meet to discuss H1N1 procurement, distribution

Representatives of African countries are meeting in Abuja this week to discuss the procurement and distribution of the H1N1 (swine flu) vaccine, the Daily Trust/allAfrica.com reports (Rabiu, 11/23).

24 Nov 2009

Medical advances abound while surgeons report concerns about medical errors

The Wall Street Journal reports on "20 health-care advances to give thanks for this Thanksgiving." Among the most key: "Life expectancy in the U.S. reached an all-time high of 77.9 years in 2007, the latest year for which statistics are available, continuing a long upward trend. (That's 75.3 years for men and 80.4 years for women.) ... Death rates dropped significantly for eight of the 15 leading causes of death in the U.S., including cancer, heart disease, stroke, hypertension, accidents, diabetes, homicides and pneumonia, from 2006 to 2007."

24 Nov 2009

OmniComm Systems chosen as Beardsworth's preferred EDC provider

OmniComm Systems, Inc., one of the fastest growing companies in the EDC marketplace, today announced that Beardsworth, a full service contract research organization (CRO) who specializes in difficult therapeutic areas, has selected OmniComm's TrialMaster EDC solution for conducting a Phase II vaccine study.

24 Nov 2009

Iowa State University's researcher develops and ships H1N1 vaccine for swine producers

The only swine vaccine available for the H1N1 virus has been sent to vaccinate a swine herd infected with the virus. The vaccination marks the first time vaccine has been sent to a swine herd diagnosed with the pandemic flu.

24 Nov 2009

Eight nonprofit organizations receive Humana Foundation Economic Response Grants

During the ongoing economic downturn that has touched the entire country, many nonprofit organizations have found their services – such as food pantries, temporary shelters and medical clinics – to be increasingly important to their communities. Complicating

24 Nov 2009

PX’Therapeutics sets up additional biomanufacturing unit

PX’Therapeutics SA (formerly known as Protein’eXpert) announces the set up of an additional biomanufacturing unit dedicated to the production of therapeutic proteins and monoclonal antibodies in mammalian cells.

24 Nov 2009

AP/News-Observer examines state of vaccine research

The Associated Press/News-Observer examines revitalized vaccine research, including for such conditions as malaria, TB and HIV. "Vaccines are no longer a sleepy, low-profit niche in a booming drug industry.

23 Nov 2009

Initiation of Phase I/IIa clinical trial of IL-7 announced

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of a Phase I/IIa clinical trial of IL-7 in support of tumor lysate/KLH pulsed dendritic cell vaccines in a pilot study of tumor vaccination in patients with metastatic or recurrent pediatric solid tumors and altered T cell homeostasis, including patients with Ewing’s sarcoma family of tumors (ESFT), rhabdomyosarcoma, neuroblastoma, synovial cell sarcoma, desmoplastic small round cell tumor, undifferentiated sarcoma, and embryonal sarcoma.

23 Nov 2009

OMA praises health care workers for their hard work and dedication during flu season

At its annual fall meeting, the Ontario Medical Association (OMA) recognized front line health care workers for their hard work and dedication to patient during this unprecedented flu season. The OMA Council, which represents doctors from across the province, overwhelmingly passed a motion to express its thanks to Medical Officers of Health, physicians, nurses, and other health care professionals for their leadership.

23 Nov 2009

Pennsylvania Department of Health commences H1N1 vaccination to members of priority groups

The Department of Health today began providing free H1N1 flu shots to members of priority groups that did not have previous access to the vaccine.

21 Nov 2009

Publication serves as a guide to build productive partnerships and overcome global health challenges

Meaningful and lasting progress in addressing global health challenges cannot be achieved without partnerships and collaboration, according to a publication released today, Case Studies for Global Health.

21 Nov 2009

First nationwide human immunology registry for infectious disease research

RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide human immunology registry for infectious disease research. The new registry was developed to help clinicians and researchers better understand the human immune response to emerging and re-emerging infectious diseases.

21 Nov 2009

Evidence does not connect H1N1 vaccine to patient deaths, WHO says

The deaths of 41 people from six countries who had received the H1N1 (swine flu) vaccine were not directly linked to the vaccine, the WHO said Thursday, the Associated Press/MSNBC reports (11/19).

20 Nov 2009

News outlets examine malaria drug resistance, hope for malaria eradication in Africa

Experts at an American Society of Tropical Medicine and Hygiene meeting this week said that resistance to the best available drug to treat malaria "is more widespread in Southeast Asia than previously reported," Science News/Wired Science reports. Researchers have been monitoring drug resistance along the Thailand-Cambodia border where patients taking artemisinin combination therapy - the most potent treatment for malaria - have been clearing the parasite from their bodies more slowly.

20 Nov 2009

Antigenics to withdraw its MAA for Oncophage following CHMP’s negative opinion

Antigenics Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has formally adopted a negative opinion on the marketing authorization application (MAA) for Oncophage (vitespen) as a treatment in earlier-stage, localized renal cell carcinoma (kidney cancer).

20 Nov 2009

Vaccine News and Research

Latest Vaccine News and Research

Pennsylvanians at-risk for H1N1 flu receive H1N1 vaccination

Health watch: When you eat just as vital to what you eat

Emerging cancer vaccines: Forecasts, new developments and pipeline analysis

Pharmaceutical research and biotechnology companies test medicines and vaccines to treat HIV/AIDS

Several new vaccines require booster shots to remain effective during a lifetime: Study

Africa region leaders meet to discuss H1N1 procurement, distribution

Medical advances abound while surgeons report concerns about medical errors

OmniComm Systems chosen as Beardsworth's preferred EDC provider

Iowa State University's researcher develops and ships H1N1 vaccine for swine producers

Eight nonprofit organizations receive Humana Foundation Economic Response Grants

PX’Therapeutics sets up additional biomanufacturing unit

AP/News-Observer examines state of vaccine research

Initiation of Phase I/IIa clinical trial of IL-7 announced

OMA praises health care workers for their hard work and dedication during flu season

Pennsylvania Department of Health commences H1N1 vaccination to members of priority groups

Publication serves as a guide to build productive partnerships and overcome global health challenges

First nationwide human immunology registry for infectious disease research

Evidence does not connect H1N1 vaccine to patient deaths, WHO says

News outlets examine malaria drug resistance, hope for malaria eradication in Africa

Antigenics to withdraw its MAA for Oncophage following CHMP’s negative opinion

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Vaccine News and Research

Latest Vaccine News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in